4basebio to present at Biotech Showcase 2026
Powering the Next-Generation Genomics Revolution: 4basebio's Synthetic DNA Platform and Strategic Vision
Cambridge, UK, 08 January 2026 – 4basebio PLC (AIM: 4BB) announced that it will present at Biotech Showcase™ 2026. This year, registered attendees can view 4basebio’s presentation live. With 24x7 on-demand access, attendees can view recorded presentations at their convenience when scheduling does not allow viewing during the main event week.
Amy Walker, PhD, Chief Operating Officer, will be representing 4basebio at Biotech Showcase and presenting on Tuesday, January 13th at 3:30pm PST.
"We're excited to present our synthetic DNA technology at this year's Biotech Showcase and share how we're empowering biotech and pharmaceutical partners to accelerate the development of next-generation genetic medicines. Our proprietary technology platform significantly reduces manufacturing timelines and costs compared to traditional bacterial-based methods, minimizes contamination risk through our cell-free synthesis approach, and ultimately helps our partners deliver safer, more reliable products to patients who need them most”, commented Dr. Walker. “As genetic medicines continue to transform healthcare, we believe our technology provides the foundation that innovators need to move from discovery to clinical application faster and more efficiently than ever before."
Biotech Showcase, produced by Demy-Colton and EBD Group, is an investor conference focused on driving advances in therapeutic development by providing a sophisticated networking platform for executives and investors that fosters investment and partnership opportunities. The conference takes place each year in San Francisco during the course of one of the industry's largest gatherings and busiest weeks.
“We are delighted that 4basebio will be joining us in San Francisco and presenting at Biotech Showcase this year,” said Sara Demy, CEO of Demy-Colton. “Biotech Showcase is a prime opportunity for life science entrepreneurs and investors to come together to discover the potential of innovative technologies that will drive the future of human health.”
About Biotech Showcase
Biotech Showcase is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place. Investors and biopharmaceutical executives from around the world gather at Biotech Showcase during this bellwether week which sets the tone for the coming year. Now in its 17th year, this well-established, highly respected conference features multiple tracks of presenting companies, plenary sessions, workshops, networking, and the opportunity to schedule one-to-one meetings. Biotech Showcase is produced by Demy-Colton and EBD Group. Both organizations have a long history of producing high-quality programs that support the biotechnology and broader life sciences industry.
About 4basebio
4basebio (AIM: 4BB) is an innovation-driven life biotechnology company focused on accelerating the development of advanced therapy medicinal products (ATMPs) through its high-performance synthetic DNA products and non-viral, cell-targeting nucleic acid delivery platform. The Company’s objective is to become a market leader in the manufacture and supply of high-quality synthetic DNA products for research, therapeutic and pharmacological use as well as development of target specific non-viral vectors for the efficient delivery of payloads in patients.